Idera Pharmaceuticals reported $-4178000 in Pre-Tax Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Abbott ABT:US $ 2973M 926M
Agenus AGEN:US $ -50.6M 17M
Alnylam Pharmaceuticals ALNY:US $ -274.67M 35.32M
Biogen BIIB:US $ 874.8M 28.6M
Biomarin Pharmaceutical BMRN:US $ 34.85M 8.66M
Dynavax Technologies DVAX:US $ 129.37M 96.52M
Idera Pharmaceuticals IDRA:US $ -4.18M 0.06M
Mirati Therapeutics MRTX:US $ -176.44M 11.94M
Nektar Therapeutics NKTR:US $ -158.97M 68.7M
Sarepta Therapeutics SRPT:US $ -228.09M 123.95M
Ultragenyx Pharmaceutical RARE:US $ -157.86M 6.1M